First name: Aurelie
  Last name: Cointe
  Position: Student
  Email: aurelie.cointe

Research interest



2018 : Doctorat 1ère année – INSERM UMR 1137 (Iame team2 -EVRest)
2016-2017 : Master 2 Microbiology (Paris XI university)
2008-2012: First and second cycle of pharmaceutical studies (Paris V University)

Academic positions

2013-2018 : Resident, Assistance Publique-Hôpitaux de Paris

Exhaustive list of publications


Birgy A, Madhi F, Jung C, Levy C, Cointe A, Bidet P, Hobson CA, Bechet S, Sobral E, Vuthien H, Ferroni A, Aberrane S, Cuzon G, Beraud L, Gajdos V, Launay E, Pinquier D, Haas H, Desmarest M, Dommergues MA, Cohen R, Bonacorsi S, GotNOoUtIdtEpEic
Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
The Journal of Antimicrobial Chemotherapy 2020, 75, 96-105.

Joseph A, Cointe A, Mariani Kurkdjian P, Rafat C, Hertig A
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.
Toxins 2020, 12,


Cointe A, de Ponfilly GP, Munier AL, Bachir M, Benmansour H, Crémieux AC, Forien M, Frazier A, Krief E, Cambau E, Jacquier H
Native joint septic arthritis due to Clostridium tarantellae.
Anaerobe 2019, 56, 46-48.

Cointe A, Birgy A, Bridier-Nahmias A, Mariani-Kurkdjian P, Walewski V, Lévy C, Cohen R, Fach P, Delannoy S, Bidet P, Bonacorsi S
Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options.
The Journal of Antimicrobial Chemotherapy 2019

Birgy A, Levy C, Nicolas-Chanoine MH, Cointe A, Hobson CA, Magnan M, Bechet S, Bidet P, Cohen R, Bonacorsi S
Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.
Antimicrobial Agents and Chemotherapy 2019, 63,

Hobson CA, Bonacorsi S, Fahd M, Baruchel A, Cointe A, Poey N, Jacquier H, Doit C, Monjault A, Tenaillon O, Birgy A
Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy.
Antimicrobial Agents and Chemotherapy 2019, 63,

Cointe A, Walewski V, Hobson CA, Doit C, Bidet P, Dortet L, Bonacorsi S, Birgy A
Rapid Carbapenemase Detection With Xpert Carba-R V2 Directly On Positive Blood Vials.
Infection and Drug Resistance 2019, 12, 3311-3316.


Cointe A, Bonacorsi S, Truong J, Hobson C, Doit C, Monjault A, Bidet P, Birgy A
Detection of Carbapenemase-Producing Enterobacteriaceae in Positive Blood Culture Using an Immunochromatographic RESIST-4 O.K.N.V. Assay.
Antimicrobial Agents and Chemotherapy 2018, 62,

Caméléna F, Cointe A, Mathy V, Hobson C, Doit C, Bercot B, Decré D, Podglajen I, Dortet L, Monjault A, Bidet P, Bonacorsi S, Birgy A
Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.
Journal of Clinical Microbiology 2018, 56,

Cointe A, Birgy A, Mariani-Kurkdjian P, Liguori S, Courroux C, Blanco J, Delannoy S, Fach P, Loukiadis E, Bidet P, Bonacorsi S
Emerging Multidrug-Resistant Hybrid Pathotype Shiga Toxin-Producing Escherichia coli O80 and Related Strains of Clonal Complex 165, Europe.
Emerging Infectious Diseases 2018, 24, 2262-2269.